Montega reiterates Buy on AlzChem, sets EUR 220 price target

PUBT · 2d ago
Montega reiterates Buy on AlzChem, sets EUR 220 price target
  • Montega reiterated a Buy rating on AlzChem, keeping its 12-month price target at EUR 220.
  • Q2 revenue rose 8.7% year over year to EUR 155.3 million, beating Montega’s EUR 147 million estimate.
  • Q2 EBITDA increased 10.7% to EUR 32.2 million, despite pressure in Basics & Intermediates.
  • Guidance stayed unchanged at about EUR 600 million revenue, about EUR 126 million EBITDA.
  • Montega flagged capacity expansion progress, including a nitroguanidine ramp-up in Germany starting in H2.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AlzChem Group AG published the original content used to generate this news brief via EQS News (Ref. ID: rc_26340) on July 30, 2026, and is solely responsible for the information contained therein.